Autoantigen-pulsed dendritic cells constitute a beneficial cytokine and growth factor network in ameliorating experimental allergic encephalomyelitis

Multiple Sclerosis

Volumn 11, Issue 4, 2005, Pages 381-389

  Liu, Xuan ^a,b   Ciumas, Carolina ^a   Huang, Yu Min ^a   Steffensen, Knut R ^a   Lian, Hong ^a   Link, Hans ^a   Xiao, Bao Guo ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Cytokine; Dendritic cells; Experimental allergic encephalomyelitis; Growth factor; Inflammation

Indexed keywords

AUTOANTIGEN; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; CYTOKINE; DENDRITIC CELL VACCINE; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; GAMMA INTERFERON; GELATINASE A; GELATINASE B; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; LIGAND; MESSENGER RNA; MYELIN BASIC PROTEIN; MYELIN BASIC PROTEIN[68-86]; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIN; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR C; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROGRAMMED DEATH LIGAND 1; PROGRAMMED DEATH LIGAND 2; SPINAL CORD DERIVED GROWTH FACTOR; STAT4 PROTEIN; STAT6 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; IMMUNIZATION; MICROENVIRONMENT; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD; UPREGULATION;

ANIMALS; AUTOANTIGENS; CYTOKINES; DENDRITIC CELLS; DNA PRIMERS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GROWTH SUBSTANCES; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED LEW;

EID: 22144477166     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458505ms1180oa     Document Type: Article

References (43)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271-96.
2. Link H, Huang YM, Xiao BG. Dendritic cells in experimental allergic encephalomyelitis and multiple sclerosis. J Neuroimmunol 1999; 100: 102-10.
3. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21: 685-711.
4. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002; 23: 445-49.
5. Maldonado-Lopez R, De Smedt T, Pajak B, Heirman C, Thielemans K, Leo O et al. Role of CD8alpha+ and CD8alpha- dendritic cells in the induction of primary immune, responses in vivo. J Leukoc Biol 1999; 66: 242-46.
6. Schuler G, Schuler-Thurner B, Steinman RM. The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 2003; 15: 138-47.
7. Kumamoto T, Morita A, Takashima A. Recent advances in dendritic cell vaccines for cancer treatment. J Dermatol 2001; 28: 658-62.
8. Weir CR, Nicolson K, Backstrom BT. Experimental autoimmune oncephalomyelitis induction in naive mice by dendritic cells presenting a self-peptide. Immunol Cell Biol 2002; 80: 14-20.
9. Dittel BN, Visintin I, Merchant RM, Janeway CA Jr. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. J Immunol 1999; 163: 32-39.
10. Watanabe H, Inaba M, Adachi Y, Sugiura K, Hisha H, Iguchi T et al. Experimental autoimmune thyroiditis induced by thyroglobulin-pulsed dendritic cells. Autoimmunity 1999; 31: 273-82.
11. Huang YM, Yang JS, Xu LY, Link H, Xiao BG. Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats. Clin Exp Immunol 2000; 122: 437-44.
12. Xiao BG, Duan RS, Link H, Huang YM. Induction of peripheral tolerance to experimental autoimmune myasthenia gravis by acetylcholine receptor-pulsed dendritic cells. Cell Immunol 2003; 223: 63-69.
13. Krueger T, Wohlrab U, Klucken M, Schott M, Seissler J. Autoantigen-specific protection of non-obese diabetic mice from cyclophosphamide-accelerated diabetes by vaccination with dendritic cells. Diabetologia 2003; 46: 1357-65.
14. Jiang HR, Muckersie E, Robertson M, Forrester JV. Antigen-specific inhibition of experimental autoimmune uveoretinitis by bone marrow-derived immature dendritic cells. Invest Ophthalmol Vis Sci 2003; 44: 1598-607.
15. Papaccio G, Nicoletti F, Pisanti FA, Bendtzen K, Galdieri M. Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells. Endocrinology 2000; 141: 1500-505.
16. Zhang GX, Kishi M, Xu H, Rostami A. Mature bone marrow-derived dendritic cells polarize Th2 response and suppress experimental autoimmune encephalomyelitis. Mult Scler 2002; 8: 463-68.
17. Radu E, Regalia T. MHC Class II Vesicles (CIIV) within immature dendritic cells. J Cell Mol Med 2004; 8: 266-67.
18. Konnai S, Usui T, Ohashi K, Onuma M. The rapid quantitative analysis of bovine cytokine genes by real-time RT-PCR. Vet Microbiol 2003; 94: 283-94.
19. Ramos-Payan R, Aguilar-Medina M, Estrada-Parra S, Gonzalez Y, Merchand JA, Favila-Castillo L et al. Quantification of cytokine gene expression using an economical real-time polymerase chain reaction method based on SYBR Green I. Scand J Immunol 2003; 57: 439-45.
20. Wang S, Bajorath J, Flies DB, Dong H, Honjo T, Chen L. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J Exp Med 2003; 197: 1083-91.
21. Vega JA, Garcia-Suarez O, Hannestad J, Perez-Perez M, Germana A. Neurotrophins and the immune system. J Anat 2003; 203: 1-19.
22. Ransohoff RM, Howe CL, Rodriguez M. Growth factor treatment of demyelinating disease: at last, a leap into the light. Trends Immunol 2002; 23: 512-16.
23. Silva GC, Nagib PR, Chiari E, van Rooijen N, Machado CR, Camargos ER. Peripheral macrophage depletion reduces central nervous system parasitism and damage in Trypanosoma cruzi-infected suckling rats. J Neuroimmunol 2004; 149: 50-58.
24. Weller RO, Engelhardt B, Phillips MJ. Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol 1996; 6: 275-88.
25. Jee Y, Kim G, Tanuma N, Matsumoto Y. STAT expression and localization in the central nervous system during autoimmune encephalomyelitis in Lewis rats. J Neuroimmunol 2001; 114: 40-47.
26. van Oosten BW, Barkhof F, Truyen L, Boringa JB, Bertelsmann FW, von Blomberg BM et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 1996; 47: 1531-34.
27. Kassiotis G, Kollias G. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J Exp Med 2001; 193: 427-34.
28. Furlan R, Brambilla E, Ruffini F, Poliani PL, Bergami A, Marconi PC et al. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J Immunol 2001; 167: 1821-29.
29. van der Veen RC, Dietlin TA, Hofman FM. Tissue expression of inducible nitric oxide synthase requires IFN-gamma production by infiltrating splenic T cells: more evidence for immunosuppression by nitric oxide. J Neuroimmunol 2003; 145: 86-90.
30. Giovannoni G, Heales SJ, Land JM, Thompson EJ. The potential role of nitric oxide in multiple sclerosis. Mult Scler 1998; 4: 212-16.
31. Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y et al. Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 2002; 169: 5538-45.
32. Tamura H, Ogata K, Dong H, Chen L. Immunology of B7-H1 and its roles in human diseases. Int J Hematol 2003; 78: 321-28.
33. Selenko-Gebauer N, Majdic O, Szekeres A, Hofler G, Guthann E, Korthauer U et al. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J Immunol 2003; 170: 3637-44.
34. Wang W, Ostlie NS, Conti-Fine BM, Milani M. The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cells. J Immunol 2004; 172: 97-103.
35. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia 2002; 39: 279-91.
36. Webster HD. Growth factors and myelin regeneration in multiple sclerosis. Mult Scler 1997; 3: 113-20.
37. Althaus HH. Remyelination in multiple sclerosis: a new role for neurotrophins? Prog Brain Res 2004; 146: 415-32.
38. Linker RA, Maurer M, Gaupp S, Martini R, Holtmann B, Giess R et al. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat Med 2002; 8: 620-24.
39. Micera A, Properzi F, Triaca V, Aloe L. Nerve growth factor antibody exacerbates neuropathological signs of experimental allergic encephalomyelitis in adult Lewis rats. J Neuroimmunol 2000; 104: 116-23.
40. Ruffini F, Furlan R, Poliani PL, Brambilla E, Marconi PC, Bergami A et al. Fibroblast growth factor-II gone therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Ther 2001; 8: 1207-13.
41. Micera A, Vigneti E, Aloe L. Changes of NGF presence in nonneuronal cells in response to experimental allergic encephalomyelitis in Lewis rats. Exp Neurol 1998; 154: 41-46.
42. Villoslada P, Hauser SL, Bartke I, Unger J, Heald N, Rosenberg D et al. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J Exp Med 2000; 191: 1799-806.
43. Hammarberg H, Lidman O, Lundberg C, Eltayeb SY, Gielen AW, Muhallab S et al. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci 2000; 20: 5283-91.